BioMark Diagnostics Inc.
BUX
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2,702.92% | 140.63% | -75.22% | -10.79% | -51.14% |
| Total Receivables | 127.24% | -1.40% | 119.82% | -28.62% | -11.42% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1,559.21% | 46.56% | -39.95% | -14.64% | -48.78% |
|
|
|||||
| Total Current Assets | 1,559.21% | 46.56% | -39.95% | -14.64% | -48.78% |
| Net Property, Plant & Equipment | -33.14% | -13.56% | -6.08% | -7.47% | -12.69% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.69% | -6.32% | 1.20% | -0.79% | 133.33% |
| Total Assets | 257.89% | -6.23% | -11.62% | -8.58% | -21.29% |
|
|
|||||
| Total Accounts Payable | -43.71% | 7.41% | 182.90% | 1.97% | 72.10% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -29.66% | 3.98% | 11.21% | 3.84% | -13.19% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 218.07% | -52.20% | -42.90% | -9.47% | -22.22% |
| Total Finance Division Other Current Liabilities | 0.00% | -6.45% | 1.64% | -1.61% | -1.59% |
| Total Other Current Liabilities | 0.00% | -6.45% | 1.64% | -1.61% | -1.59% |
| Total Current Liabilities | -18.84% | -2.09% | 17.62% | -0.15% | -10.92% |
|
|
|||||
| Total Current Liabilities | -18.84% | -2.09% | 17.62% | -0.15% | -10.92% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -29.66% | 3.98% | 11.21% | 3.84% | -13.19% |
| Capital Leases | -64.58% | -6.13% | 15.02% | -12.85% | -18.95% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -29.36% | -3.05% | 16.99% | -3.54% | -13.23% |
|
|
|||||
| Common Stock & APIC | 32.59% | -6.00% | 2.17% | 3.73% | -2.54% |
| Retained Earnings | -2.85% | 4.02% | -5.14% | -6.43% | -0.45% |
| Treasury Stock & Other | -- | 24.84% | 8.45% | 104.60% | -- |
| Total Common Equity | 258.74% | 0.35% | -61.34% | -5.42% | -6.20% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 258.74% | 0.35% | -61.34% | -5.42% | -6.20% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 258.74% | 0.35% | -61.34% | -5.42% | -6.20% |
|
|
|||||